Albuterol: all 174 studies that test it

Page 1 of 2. Open to participants first (20), then studies with results posted, then the rest; newest registration first within each.

• Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial FibrillationRecruitingNCT07877519Not applicable
• The Role Intraoperative Salbutamol Inhaler in Preventing AtelectasisNot yet recruitingNCT07591558Early Phase 1
• Ventilation and Perfusion in AsthmaticsRecruitingNCT07426458Phase 4
• Effect of Intraoperative Salbutamol Administration on Mechanical Power and Respiratory Mechanics in Obese Patients Undergoing Laparoscopic Bariatric SurgeryNot yet recruitingNCT07378605Not applicable
• The Effectiveness of Inhaled Salbutamol in the Management of Transient Tachypnea of the Newborn(TTN)Not yet recruitingNCT07350421Not applicable
• 45th Multicenter Airway Research CollaborationRecruitingNCT07166939Phase 4
• Effects of Salbutamol in Athletes and Implications for Screening and SportsRecruitingNCT07037511Not applicable
• Characterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic FeaturesRecruitingNCT06946264Phase 3
• Physiological Effects of Nebulized Salbutamol in Acute Respiratory Failure Patients on HFNCNot yet recruitingNCT06815679Phase 2/3
• Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals LtdNot yet recruitingNCT06618105Phase 3
• A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 InclusiveRecruitingNCT06433921Phase 1
• Deciphering a Novel and Unique Brown Adipose Tissue Depot in WomenNot yet recruitingNCT06426082Not applicable
• The Regulatory Function of Inhaled Asthma Medication Salbutamol on ThermogenesisNot yet recruitingNCT06319183Early Phase 1
• Nebulized Salbutamol in Acute Renal ColicNot yet recruitingNCT06276231Not applicable
• Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation ImagingRecruitingNCT06271408Phase 1
• Comparison of Preoperative Inhaled Budesonide With Salbutamol on the Respiratory Adverse Effects in Children Undergoing TonsillectomyNot yet recruitingNCT06158893Phase 4
• Evaluating Bronchodilator Response in Patients With BronchiectasisRecruitingNCT05932316Not applicable
• Effect of Salbutamol on Walking Capacity in Ambulatory ALS PatientsNot yet recruitingNCT05860244Phase 2
• Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)RecruitingNCT05550402Not applicable
• Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients with Stable Mild AsthmaRecruitingNCT04912596Not applicable
• A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 InclusiveCompletedNCT06433908Phase 1Results posted
• A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With AsthmaCompletedNCT06261957Phase 3Results posted
• Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy ParticipantsCompletedNCT05791565Phase 1Results posted
• Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90mcg Per Actuation in Healthy Volunteers Under Fasting ConditionsCompletedNCT05300087Not applicableResults posted
• Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB)CompletedNCT05087693Phase 4Results posted
• Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to PhenotypeCompletedNCT04901715Early Phase 1Results posted
• Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108 mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90 mcg Per Actuation in Healthy Volunteers Under Fasting ConditionsCompletedNCT04803734Not applicableResults posted
• A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With AsthmaCompletedNCT04677959Phase 4Results posted
• Peak Inspiratory Flow and Dry Powder Inhaler Performance in COPDCompletedNCT04606394Phase 4Results posted
• An Exploratory Study to Characterise Changes in Airway Inflammation, Symptoms, Lung Function and Reliever Use in Adult Asthma PatientsCompletedNCT03924635Phase 4Results posted
• The Effect of NAC on Lung Function and CT Mucus ScoreTerminatedNCT03822637Phase 4Results posted
• Reducing Exercise-induced Bronchoconstriction in Children With Asthma and ObesityTerminatedNCT03586544Phase 4Results posted
• Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With AsthmaCompletedNCT03364608Phase 2Results posted
• Effect of Inhaled Albuterol in Pulmonary HypertensionCompletedNCT03270332Phase 2Results posted
• Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03256695Phase 3Results posted
• A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With AsthmaCompletedNCT02969408Phase 3Results posted
• Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled TrialCompletedNCT02885636Phase 3Results posted
• Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy AdultsCompletedNCT02802111Not applicableResults posted
• Aerosolized Albuterol Use in Severe BPDCompletedNCT02766673Not applicableResults posted
• Albuterol to Improve Respiratory Strength in SCITerminatedNCT02508311Phase 4Results posted
• Preterm Infant Inhaled Albuterol DosingCompletedNCT02447250Phase 4Results posted
• A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With AsthmaCompletedNCT02233803Phase 4Results posted
• The Various Effects of Gaseous Albuterol on Serum LactateCompletedNCT02073747Not applicableResults posted
• The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial DysautonomiaCompletedNCT01987219Phase 3Results posted
• Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric PatientsCompletedNCT01899144Phase 2Results posted
• Safety and Efficacy of Albuterol in Individuals With Late-onset Pompe DiseaseCompletedNCT01885936Phase 1/2Results posted
• Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic FibrosisCompletedNCT01880723Not applicableResults posted
• Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)CompletedNCT01857323Phase 3Results posted
• Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)CompletedNCT01791972Phase 3Results posted
• Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01721291Phase 4Results posted
• Safety Study of Albuterol Spiromax® in Subjects With AsthmaCompletedNCT01698320Phase 3Results posted
• A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and IpratropiumCompletedNCT01691482Phase 4Results posted
• A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With AsthmaCompletedNCT01641692Phase 2Results posted
• Efficacy and Safety of Increasing Doses of Inhaled Albuterol in Children With Acute Wheezing EpisodesCompletedNCT01323010Not applicableResults posted
• A Study of LY2216684 in Healthy Participants Receiving Albuterol or PropanololCompletedNCT01263197Phase 1Results posted
• Respiratory Impedance and Obliterative BronchiolitisCompletedNCT01255449Not applicableResults posted
• A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed DosingTerminatedNCT01218009Phase 3Results posted
• Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot StudyCompletedNCT01196377Not applicableResults posted
• Effect of Nebulized Bronchodilators on Heart RateCompletedNCT01151579Phase 4Results posted
• Characterization of Placebo Responses in Stable AsthmaCompletedNCT01143688Not applicableResults posted
• Bronchodilator Responsiveness in Obliterative BronchiolitisCompletedNCT01112241Phase 4Results posted
• A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent AsthmaCompletedNCT01058863Phase 2Results posted
• Dose-response of Albuterol in AsthmaticsCompletedNCT00940927Phase 4Results posted
• Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00669617Phase 3Results posted
• Albuterol HFA MDI in Pediatric Participants With AsthmaCompletedNCT00577655Phase 3Results posted
• Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With AsthmaCompletedNCT00530062Phase 4Results posted
• Drug Study of Albuterol to Treat Acute Lung InjuryTerminatedNCT00434993Phase 2/3Results posted
• Results Of Patient Rated Asthma Control Test In Comparison To Diary Card DataCompletedNCT00363480Phase 4Results posted
• Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric AsthmaticsCompletedNCT00308685Phase 3Results posted
• Role of Salbutamol in the Management of Transient Tachypnea of the New BornCompletedNCT06921291Phase 1
• A Comparative Study of Adding Ipratropium to Salbutamol for the Treatment of Asthma Attack in ChildrenCompletedNCT06918418Phase 4
• Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild AsthmaCompletedNCT06563102Phase 4
• CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in AsthmaActive, not recruitingNCT06482294Phase 2
• 5 Versus 10 Units of Insulin in Hyperkalemia ManagementCompletedNCT06036823Phase 4
• Cardiovascular Consequences of Inhaled Short-acting Beta-agonist UseCompletedNCT06027606Phase 1
• INhaled Salbutamol vs Placebo for the Treatment of Acute IgE-mediated Abdominal Pain From Allergic Food REactionsTerminatedNCT05653024Phase 3
• Nebulized Salbutamol Facilitate Management of Hyperkalemia Postreperfusion During Liver TransplantationStatus unknownNCT05589441Not applicable
• the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)Active, not recruitingNCT05527704Phase 3
• Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no TreatmentCompletedNCT05099107Not applicable
• Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN)CompletedNCT05006235Phase 1
• Physiologic Performance Response to SalbutamolStatus unknownNCT04615611Not applicable
• Bronchodilators for Wheeze in Young Children Presenting to Primary Care: a Randomised, Placebo-controlled, Multicentre, Parallel Group TrialWithdrawnNCT04584034Phase 4
• Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPDWithdrawnNCT04446637Phase 3
• Can Anti-asthmatic Medication Improve Sprint Performance in Healthy Endurance Athletes?WithdrawnNCT04402658Not applicable
• Mechanisms for Dyspnea on Exertion in Children With Obesity and Asthma: Distinct Physiological PhenotypesWithdrawnNCT04184609Phase 4
• Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute HyperkalemiaCompletedNCT04012138Phase 4
• Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia GravisStatus unknownNCT03914638Phase 2/3
• Physiological Response to Salbutamol and ExerciseStatus unknownNCT03902106Not applicable
• Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic AsthmaCompletedNCT03620422Not applicable
• Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg BaseStatus unknownNCT03549897Phase 3
• CF BronchodilationActive, not recruitingNCT03522831Not applicable
• Status Asthmaticus on the PICU; Intravenous SalbutamolCompletedNCT03493503Phase 4
• Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPDCompletedNCT03480997Phase 1
• High-flow Nasal Cannula Nebulization of Beta 2 Adrenergic Agonist During Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseStatus unknownNCT03449056Phase 3
• Effects of Noninvasive Ventilation Compared to SalbutamolCompletedNCT03430505Not applicable
• Nebulized Heparin and Salbutamol in Mechanically Ventilated Patients With AECOPDCompletedNCT03333395Phase 4
• Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized BronchodilatorStatus unknownNCT03271905Not applicable
• A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular SystemsTerminatedNCT03098680Phase 1
• Evaluation on the Efficacy of Bronchodilator Nebulization Via High Flow Nasal CannulaCompletedNCT03091504Not applicable
• Acute Effect of Salbutamol on Heart Rate and Blood Pressure During Exercise in Patients With Moderate or Severe Asthma and Healthy SubjectsCompletedNCT03044938Phase 4

← Albuterol overview